Kenneth Londoner, Founder, Chairman and CEO By Len Zehr With the FDA’s 510(k) clearance of its PURE EP System in August 2018 and first successful patient cases, BioSig (NASDAQ:BSGM) is advancing its vision to improve...
By Len Zehr Closely-held NuPulseCV is enrolling patients with advanced heart failure in a feasibility study with its intravascular ventricular assist system (iVAS), a minimally invasive heart pump designed to allow...
By Len Zehr Closely-held Vessi Medical wants to change the standard of care for superficial bladder cancer by using a surface cryotherapy approach in a minimally invasive in-office treatment alternative to surgery. “We...
By Len Zehr After recently conducting five first-in-man coronary stent procedures robotically in India, Corindus Vascular Robotics (NASDAQ:CVRS) plans to perform its first remote vascular cases in the U.S. in mid-2019...
By Len Zehr Closely-held DxTerity has developed the first affordable diagnostics platform for at-home monitoring of autoimmune disease activity and response to drug treatment, with tests that use longitudinal gene...
By Len Zehr As a principal of closely-held MIDI Medical Product Development, Greg Montalbano has a unique background in industrial design, usability/ergonomics and manufacturing with over 25 years of experience...
By Len Zehr Closely-held PharmaJet’s needle-free injection devices have the potential to rapidly improve the delivery of vaccines in emerging markets as well as pharmaceuticals currently under development. “We are at...
By Len Zehr Closely-held Lineagen has developed and commercialized a comprehensive portfolio of behavioral screening and genetic tests for autism spectrum disorders (ASD) and other forms of childhood neurodevelopmental...
ImpediMed’s (ASX:IPD) transition to a software-as-a-service (SaaS) subscription business model in 2018, in conjunction with the introduction of the SOZO Digital Health Platform, is already paying off on the top line.
Closely-held Interface Biologics, best known for improving the safety and efficacy of medical devices through its Endexo surface modification technology, is pegging its future growth on biotech, with an initial focus on...